News Press release

Press Release: Cure Parkinson’s welcomes Mike Ashton as new chair of trustees

18 June 2024 Mike Ashton joined the board towards the end of 2023, bringing with him extensive experience in business growth strategy, brand and marketing management and governance in both the private and charity sectors. Mike said: “I’ve been impressed and inspired by everything I’ve…


Press release

Press Release: Fundraiser of the Year 2023

11 April 2024 We are thrilled to announce that we have two winners of our 2023 Fundraiser of the Year Award: Antony Rose and Michelle Gillies! These two incredible supporters went ‘above and beyond’ to support our vital research by spending 2023 raising funds and…


Press release

Press Release: Phase 2 clinical trial of Type 2 diabetes drug for treatment of Parkinson’s shows positive and promising results

3 April 2024 Results from a one-year, phase 2 clinical trial of the Type 2 diabetes drug lixisenatide suggest that the treatment may slow the progression of motor symptoms in Parkinson’s disease. The study is published on 4 April in The New England Journal of…


Press release

Press Release: Phase 2 clinical trial of dapansutrile for Parkinson’s confirmed

23 February 2024 Cure Parkinson’s, in partnership with Van Andel Institute, is delighted to announce funding for a Phase 2 clinical of dapansutrile, an anti-inflammatory drug, to determine whether it can slow the progression of Parkinson’s. The DAPA-PD trial will evaluate the safety and tolerability…


Press release

Press Release: Cure Parkinson’s welcomes Rory Cellan-Jones as new patron

7 February 2024 Cure Parkinson’s is delighted to announce that Rory Cellan-Jones, former technology correspondent for the BBC, writer, ‘Movers & Shakers’ podcaster, technology advisor and owner of one the UK’s most beloved rescue dogs, has joined Cure Parkinson’s as a patron. Rory was diagnosed…